Remove category videos ai-ml
article thumbnail

How the use of AI is impacting life sciences manufacturing

Dot Compliance

Today, 45% of life sciences companies’ technology investments are made in three analytics-related technologies – applied AI, industrialized machine learning (ML), and cloud and edge computing. In a survey of BioPharma leaders, 75% said they plan to invest more in AI in the next five years.

FDA 52
article thumbnail

Part 2: Who Regulates Healthcare AI?

AIHC

Artificial Intelligence & Regulatory Compliance Written by Joanne Byron , BS, LPN, CCA, CHA, CHCO, CHBS, CHCM, CIFHA, CMDP, COCAS, CORCM, OHCC, ICDCT-CM/PCS This article follows Part 1 - Basics of Artificial Intelligence (AI) and Healthcare Compliance published by AIHC on June 6, 2023. So, Who Regulates Healthcare AI?

FDA 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

The products had been improperly regularized in ANVISA as cosmetics since they are indicated for injectable use, a form that is not authorized for this category of product. The purpose of the note is to clarify that products for invasive aesthetic treatments cannot be regularized in the category of cosmetics.

FDA 52
article thumbnail

Medicare Remote Therapeutic Monitoring: Top FAQs for 2023

Healthcare Law Today

The two RTM treatment management codes (CPT codes 98980 and 98981) were initially created under the “General Medicine” category, not the “E/M Services” category. via phone or video). However, for other qualified health care practitioners (e.g.,